Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
Bridge Therapeutics Inc. logo — Safe alternatives to Opioids

Bridge Therapeutics Inc.

Safe alternatives to Opioids

Founded 2016 United States Birmingham, United States 6 employees

General Information

Company Name Bridge Therapeutics Inc.
Founded Year 2016
Location United States Birmingham, United States +1
Employees 6
Social

Get notified when Bridge Therapeutics Inc. moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Bridge Therapeutics Inc.

Bridge Therapeutics®, based in Birmingham, Ala., is an innovative development-stage specialty pharmaceutical company pursuing U.S. Food and Drug Administration (FDA) and European Medicines Agency (EMA) approvals of a patented (U.S. Patent #8410092) drug combination, BT-205, for the treatment of chronic pain in opioid-experienced patients. The investigational drug BT-205 is a unique combination of two synergistic chronic pain drugs—the partial-agonist opioid buprenorphine and the NSAID meloxicam—delivered in a state-of-the-art sublingual formulation. The dosing and delivery method will be a commercial advantage over the current alternatives. Bridge Therapeutics'​ goal is to make the BT-205 compound and other investigational new drug candidates available to millions of patients in which addictive and potentially dangerous full-agonist opioids such as oxycodone and morphine are ineffective and/or unsatisfactory. For more information, visit www.bridgetherapeutics.com.

No funding data available for Bridge Therapeutics Inc. yet.

Get notified when Bridge Therapeutics Inc. raises funding

Bridge Therapeutics Inc. Alternatives & Competitors

Bridge Therapeutics Inc. vs
OPOS
OPOS United States

Quality of Life is the Health Outcome.

Grant
13 employees
Health Care
Bridge Therapeutics Inc. vs
Adolore Biotherapeutics
Adolore Biotherapeutics

Pioneering Non-Opioid Analgesic Gene Therapies for Chronic Pain

5 employees
Biotechnology, Health Care
Bridge Therapeutics Inc. vs
Centrexion Therapeutics Corp.
Centrexion Therapeutics Corp. United States

We aim to relieve the suffering associated with chronic pain by creating treatments that address the...

Series Unknown
23 employees
Biotechnology, Health Care

FAQ About Bridge Therapeutics Inc.

Safe alternatives to Opioids
Bridge Therapeutics Inc. was founded in 2016.
Bridge Therapeutics Inc. is headquartered in Birmingham, United States.
Bridge Therapeutics Inc. has approximately 6 employees.
Top alternatives and competitors to Bridge Therapeutics Inc. include OPOS, Adolore Biotherapeutics, Centrexion Therapeutics Corp., MAXONA Pharmaceuticals, Sustained Therapeutics. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Bridge Therapeutics Inc. and OPOS are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Bridge Therapeutics Inc. and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

One analytics cookie (Google Analytics). Cookie Policy

Book a demo 30 minutes